Pricing Log in Create free account

Bio-Path Holdings, Inc. (BPTH) vs Lakewood-Amedex Biotherapeutics Inc. (LABT)

Bio-Path Holdings, Inc. and Lakewood-Amedex Biotherapeutics Inc. are both Biotechnology companies. Lakewood-Amedex Biotherapeutics Inc. is the larger, with a market value of $1.3M against $1.1M — 1.2× the size. Across the 8 metrics below, Bio-Path Holdings, Inc. leads on 5 and Lakewood-Amedex Biotherapeutics Inc. on 3.

Valuation

Metric BPTH LABT Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m 0.12 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.00 0.71 0.66
EV/Sales n/m n/m 9.02
Earnings yield 0.00% (2,135.14%) (32.88%)
Free cash flow yield 0.00% (934.12%) (23.13%)

Profitability

Metric BPTH LABT Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 157.01% 0.00% (51.96%)
Return on assets (605.50%) (302.50%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BPTH LABT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 87.75% 15.32% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BPTH LABT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.07 7.70 4.97
Net debt to EBITDA 0.10 0.06 1.01

Dividend

Metric BPTH LABT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BPTH LABT Biotechnology median
Market cap 1.07m 1.27m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack